Georgia Cancer Specialists Plays Key Role in Approval of Revolutionary ‘Smart Bomb’ Breast Cancer Drug
Women with HER2+ Breast Cancer Have a New, Targeted Treatment Option The FDA approved a new drug for advanced breast cancer on Friday, February 22, and Georgia Cancer Specialists (GCS) played an important role in the clinical trial that led to its approval. T-DM1 (Kadcyla) is approved for metastatic HER2-positive breast cancer patients whose disease […]
Ranjana Bhargava, M.D. Published in CA: A Cancer Journal for Clinicians
Dr. Bhargava Authors A Review on the Role of HPV in Nongenital Cancers February 10, 2013 (Athens) — Dr. Ranjana Bhargava of Georgia Cancer Specialists (GCS)—a Top 10 private cancer practice in the U.S.— was published in the most recent edition of CA: A Cancer Journal for Clinicans sponsored by the American Cancer Society, regarding the […]
